| Issuer | % of Class | Filed |
|---|---|---|
|
Cumberland Pharmaceuticals Inc.
13G
CPIX · 230770109
|
38.4% |
2/9/2026
Event 1/30/2026
|
|
Cumberland Pharmaceuticals Inc.
13G
CPIX · 230770109
|
40.8% |
2/13/2025
Event 2/13/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.